The Analgesic Effect of QLB II After Robotic Prostatectomy. (QLB II: Quadratus Lomborum Block II Type)

Postoperative Pain Clinical Trial

— QLBII  

Official title:

The Analgesic Effect of Qudratus Lomborum Block II Type After Robotic-Assisted Laparoscopic Radical Prostatectomy.

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03941899
• Other study ID #: 0081052
• Status: Completed
• Phase: N/A
• Start date: May 6, 2019
• Est. completion date: April 30, 2021

Study information

• Verified date: May 2021
• Source: San Salvatore Hospital of L'Aquila
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The analgesic effects of Quadratus Lomborum Block II type after robotic-assisted laparoscopic radical prostatectomy, will be assessed.

Description:

Quadratus Lomborum Block II type will be performed before performing robotic-assisted laparoscopic radical prostatectomy.

The post-operative analgesic effect will be assessed, by using Numeric Rate Scale for pain.

The pain assessment will be evaluated during the first 24 hours from surgery. The opioids requirement and side effects will be also assessed.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 48
• Est. completion date: April 30, 2021
• Est. primary completion date: December 6, 2020
• Accepts healthy volunteers: No
• Gender: Male
• Age group: 18 Years to 85 Years

Eligibility

Inclusion Criteria:

• American Society of Anesthesiologist status I-III

• Written informed consent

Exclusion Criteria:

• Body mass Index > 35 kg/m2

• Allergies to local anesthetics

• primaries or secondaries coagulopathies

• addiction to drugs

• severe kidney and liver diseases

• cognitive impairment

Related Conditions & MeSH terms

• Pain, Postoperative
• Postoperative Pain

Intervention

Other:
• Levobupivacaine in QLB II
Quadratus Lomborum Block II type will be performed by injecting levobupivacaine 0.375% 20 ml between latissimus dorsi and quadratus lomborum muscle.

Locations

Country	Name	City	State
Italy	San Salvatore Academic Hospital	Coppito	L'Aquila

Sponsors (1)

Lead Sponsor	Collaborator
San Salvatore Hospital of L'Aquila

Country where clinical trial is conducted

Italy, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Analgesia	Pain assessment by using Numeric Rate Scale for pain	The first 24 hours from surgery
Secondary	Opioids	The opioids requirement (mg of equianalgesic morphine) will be assessed	The first 24 hours from surgery
Secondary	Postoperative Nausea and Vomiting	The postoperative nausea and vomiting will be assessed	The first 24 hours from surgery
Secondary	Bowel function	The recovery of bowel function will be assessed	The first 24 hours from surgery
Secondary	Length of stay	The length of stay after surgery will be assessed	Day after surgery